Prevalence of Cardiovascular Disease in Type 2 Diabetes: a Systematic Literature Review of Scientific Evidence from Across the World in 2007-2017

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2018 Jun 10

PMID 29884191

Citations 812

Authors

Thomas R Einarson

Annabel Acs

Craig Ludwig

Ulrik H Panton

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular disease (CVD) is a common comorbidity in type 2 diabetes (T2DM). CVD's prevalence has been growing over time.

Purpose: To estimate the current prevalence of CVD among adults with T2DM by reviewing literature published within the last 10 years (2007-March 2017).

Methods: We searched Medline, Embase, and proceedings of major scientific meetings for original research documenting the prevalence of CVD in T2DM. CVD included stroke, myocardial infarction, angina pectoris, heart failure, ischemic heart disease, cardiovascular disease, coronary heart disease, atherosclerosis, and cardiovascular death. No restrictions were placed on country of origin or publication language. Two reviewers independently searched for articles and extracted data, adjudicating results through consensus. Data were summarized descriptively. Risk of bias was examined by applying the STROBE checklist.

Results: We analyzed data from 57 articles with 4,549,481 persons having T2DM. Europe produced the most articles (46%), followed by the Western Pacific/China (21%), and North America (13%). Overall in 4,549,481 persons with T2DM, 52.0% were male, 47.0% were obese, aged 63.6 ± 6.9 years old, with T2DM duration of 10.4 ± 3.7 years. CVD affected 32.2% overall (53 studies, N = 4,289,140); 29.1% had atherosclerosis (4 studies, N = 1153), 21.2% had coronary heart disease (42 articles, N = 3,833,200), 14.9% heart failure (14 studies, N = 601,154), 14.6% angina (4 studies, N = 354,743), 10.0% myocardial infarction (13 studies, N = 3,518,833) and 7.6% stroke (39 studies, N = 3,901,505). CVD was the cause of death in 9.9% of T2DM patients (representing 50.3% of all deaths). Risk of bias was low; 80 ± 12% of STROBE checklist items were adequately addressed.

Conclusions: Globally, overall CVD affects approximately 32.2% of all persons with T2DM. CVD is a major cause of mortality among people with T2DM, accounting for approximately half of all deaths over the study period. Coronary artery disease and stroke were the major contributors.

Citing Articles

Diabetes, obesity, and cardiovascular disease-what is the impact of lifestyle modification?.

Seth C, Schmid V, Mueller S, Haykowsky M, Foulkes S, Halle M Herz. 2025; .

PMID: 40085207 DOI: 10.1007/s00059-025-05309-x.

Associations between kidney function with all-cause and cause-specific mortality in type 2 diabetes mellitus patients: a prospective cohort study in China.

He J, Wan Y, Fan X, Yu H, Qin Y, Su J J Health Popul Nutr. 2025; 44(1):77.

PMID: 40083037 PMC: 11907967. DOI: 10.1186/s41043-025-00809-2.

Identifying and ranking non-traditional risk factors for cardiovascular disease prediction in people with type 2 diabetes.

Dziopa K, Chaturvedi N, Asselbergs F, Schmidt A Commun Med (Lond). 2025; 5(1):77.

PMID: 40082712 PMC: 11906859. DOI: 10.1038/s43856-025-00785-y.

Exploring Cardiovascular Health: The Role of Dyslipidemia and Inflammation.

Siripuram C, Gunde A, Hegde S, Ghetia K, Kandimalla R Cureus. 2025; 17(2):e78818.

PMID: 40078263 PMC: 11901415. DOI: 10.7759/cureus.78818.

Disproportionately raised risk of adverse outcomes in patients with COPD and comorbid type 2 diabetes or depression: Swedish register-based cohort study.

Smith C, Hasselgren M, Sandelowsky H, Stallberg B, Hiyoshi A, Montgomery S Respir Res. 2025; 26(1):84.

PMID: 40045313 PMC: 11883964. DOI: 10.1186/s12931-025-03160-6.

References

Malik S, Zhao Y, Budoff M, Nasir K, Blumenthal R, Bertoni A . Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2017; 2(12):1332-1340. PMC: 5814996. DOI: 10.1001/jamacardio.2017.4191. View

Kelsall H, Fernando P, Gwini S, Sim M . Cardiovascular Disease and Type 2 Diabetes Risk Across Occupational Groups and Industry in a Statewide Study of an Australian Working Population. J Occup Environ Med. 2017; 60(3):286-294. DOI: 10.1097/JOM.0000000000001228. View

Nair M, Prabhakaran D . Why Do South Asians Have High Risk for CAD?. Glob Heart. 2015; 7(4):307-14. DOI: 10.1016/j.gheart.2012.09.001. View

Mendis S, Davis S, Norrving B . Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015; 46(5):e121-2. DOI: 10.1161/STROKEAHA.115.008097. View

Marso S, Daniels G, Brown-Frandsen K, Kristensen P, Mann J, Nauck M . Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016; 375(4):311-22. PMC: 4985288. DOI: 10.1056/NEJMoa1603827. View

Wentworth J, Fourlanos S, Colman P . Body mass index correlates with ischemic heart disease and albuminuria in long-standing type 2 diabetes. Diabetes Res Clin Pract. 2012; 97(1):57-62. DOI: 10.1016/j.diabres.2012.02.012. View

Schnell O, Cappuccio F, Genovese S, Standl E, Valensi P, Ceriello A . Type 1 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2013; 12:156. PMC: 3816572. DOI: 10.1186/1475-2840-12-156. View

Carrasco-Sanchez F, Gomez-Huelgas R, Formiga F, Conde-Martel A, Trullas J, Bettencourt P . Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: findings from the RICA registry. Diabetes Res Clin Pract. 2014; 104(3):410-9. DOI: 10.1016/j.diabres.2014.03.015. View

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

10.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

11.

Glogner S, Rosengren A, Olsson M, Gudbjornsdottir S, Svensson A, Lind M . The association between BMI and hospitalization for heart failure in 83,021 persons with Type 2 diabetes: a population-based study from the Swedish National Diabetes Registry. Diabet Med. 2013; 31(5):586-94. DOI: 10.1111/dme.12340. View

12.

Mansour A, Ajeel N . Atherosclerotic cardiovascular disease among patients with type 2 diabetes in Basrah. World J Diabetes. 2013; 4(3):82-7. PMC: 3680628. DOI: 10.4239/wjd.v4.i3.82. View

13.

Gondim F, Caribe A, Vasconcelos K, Segundo A, Bandeira F . Vitamin D Deficiency Is Associated with Severity of Acute Coronary Syndrome in Patients with Type 2 Diabetes and High Rates of Sun Exposure. Clin Med Insights Endocrinol Diabetes. 2016; 9:37-41. PMC: 5010093. DOI: 10.4137/CMED.S39427. View

14.

Song S, Hardisty C . Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort. QJM. 2009; 102(11):799-806. DOI: 10.1093/qjmed/hcp121. View

15.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

16.

Salinero-Fort M, San Andres-Rebollo F, De Burgos-Lunar C, Abanades-Herranz J, Carrillo-de-Santa-Pau E, Chico-Moraleja R . Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease. J Diabetes Complications. 2015; 30(2):227-36. DOI: 10.1016/j.jdiacomp.2015.10.007. View

17.

Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T . Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353(25):2643-53. PMC: 2637991. DOI: 10.1056/NEJMoa052187. View

18.

Jurado J, Ybarra J, Solanas P, Caula J, Gich I, Pou J . Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study. J Am Acad Nurse Pract. 2009; 21(3):140-8. DOI: 10.1111/j.1745-7599.2008.00377.x. View

19.

Abi Khalil C, Sulaiman K, Singh R, Jayyousi A, Asaad N, Alhabib K . BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: Findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry. Int J Cardiol. 2017; 241:262-269. DOI: 10.1016/j.ijcard.2017.02.119. View

20.

Clua-Espuny J, Gonzalez-Henares M, Queralt-Tomas M, Campo-Tamayo W, Muria-Subirats E, Panisello-Tafalla A . Mortality and Cardiovascular Complications in Older Complex Chronic Patients with Type 2 Diabetes. Biomed Res Int. 2017; 2017:6078498. PMC: 5569628. DOI: 10.1155/2017/6078498. View